SB/Bristol Avandia Lipid Adverse Effect Diminishes Over Two Months - Label
Executive Summary
The adverse effect of SmithKline Beecham/Bristol-Myers Squibb's antidiabetic Avandia (rosiglitazone) on patient lipid profiles appears to level off after one to two months, labeling indicates.